Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: Two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour
- 1 August 1985
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 20 (1) , 29-37
- https://doi.org/10.1007/bf00199770
Abstract
The specific and natural killer (NK)-restricted nature of auto-tumour cytotoxicity of tumour-associated lymphocytes was studied in cancer patients with malignant pleural effusions. Large granular lymphocytes (LGL) and small T lymphocytes were isolated from carcinomatous pleural effusions by centrifugation on discontinuous Percoll gradients. Tumour cells freshly isolated from pleural effusions were classified according to their susceptibility to lysis by Percoll-purified LGL from the blood of normal donors in a 4-h 51Cr release assay. Of 12 NK-sensitive tumour samples, 11 were killed by autologous fresh effusion LGL, whereas only 2 were lysed by autologous T cells. Neither LGL nor T cells were cytotoxic to NK-resistant autologous tumour cells. T cells and LGL were each cultured in vitro with autologous tumour cells for 6 days. Effusion LGL maintained their auto-tumour killing activity in 10 of 12 autologous mixed lymphocyte-tumour cultures (MLTC) with NK-sensitive tumour, while LGL lost the activity when cultured alone. Removal of high-affinity sheep erythrocyte-rosetting cells from Percoll-purified LGL enriched effector cells. Autologous MLTC-derived LGL could also kill NK-sensitive allogeneic effusion tumour cells and K562 cells, as did fresh LGL. In autologous MLTC LGL failed to acquire lytic function to NK-resistant autologous tumour cells. In contrast, in vitro activation of effusion T cells with autologous tumour cells induced auto-tumour killer cells in 9 of 12 NK-sensitive tumour samples and 3 of 6 NK-resistant tumour cases. However, cultured T cells were incapable of killing allogeneic tumour cells and K562 cells. In the autologous MLTC effusion T cells proliferated vigorously in response to autologous tumour cells, whereas LGL showed no proliferation. The enrichment of blasts from cultured T cells on discontinuous Percoll gradients resulted in an enhancement of auto-tumour cytotoxicity, with no reactions recorded in blast-depleted, small, resting T cells. These results indicate that two distinct types of auto-tumour-recognising lymphocytes, LGL and T cells, are present in carcinomatous pleural effusions of cancer patients and that each effector type recognises different membrane moieties of autologous effusion tumour cells.Keywords
This publication has 33 references indexed in Scilit:
- DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cellsCancer Immunology, Immunotherapy, 1985
- Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytesCancer Immunology, Immunotherapy, 1984
- Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.The Journal of Immunology, 1984
- Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusionsInternational Journal of Cancer, 1983
- Human T-cell cultures with selective autotumor reactivityCancer Immunology, Immunotherapy, 1982
- Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2International Journal of Cancer, 1982
- LYSIS OF FRESH HUMAN SOLID TUMORS BY AUTOLOGOUS LYMPHOCYTES ACTIVATED INVITRO WITH LECTINS1982
- Induction of Natural Killer Cell Activity and Allocytotoxicity in Human Peripheral Blood Lymphocytes after Mixed Lymphocyte CultureScandinavian Journal of Immunology, 1981
- Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.The Journal of Experimental Medicine, 1980
- Human Tumor-Lymphocyte Interaction In Vitro. VI. Specificity of Primary and Secondary Autologous Lymphocyte-Mediated Cytotoxicity2JNCI Journal of the National Cancer Institute, 1979